Redaction in Regulatory Documents: Fundamentals 101
In a general scenario, it is important to share the clinical trial analysis to increase the scope of further research and transparency in the flow of information. However, there are different levels of information that needs to be distributed to the public. A controlled flow of information is vital to monitor that no sensitive data such as patient data listings in the clinical reports or the result summaries is distributed. This is where the concept of data redaction comes into the picture.